Advaxis Inc (NASDAQ:ADXS)

21.28
Delayed Data
As of Apr 27
 -2.06 / -8.83%
Today’s Change
2.47
Today|||52-Week Range
24.48
+165.67%
Year-to-Date

Today’s Trading

Previous close23.34
Today’s open23.33
Day’s range-- - --
Volume1,887,735
Average volume (3 months)1,484,503
Market cap$637.6M
Dividend yield--
Data as of 04/27/2015

Growth & Valuation

Earnings growth (last year)+76.34%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales54.40
Price/Book22.21

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...-0.71-5.16%
TBPHTheravance Biopharma...-1.15-6.25%
FLMLFlamel Technologies ...-0.45-2.83%
DVAXDynavax Technologies...-1.32-5.66%
Data as of 04/27/2015

Financials

Next reporting dateJuly 1, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$1.0M
Annual profit (last year)-$16.5M
Net profit margin-1,652.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
COO, Secretary, EVP &
Head-Investor Relations
Gregory T. Mayes
Corporate headquarters
Princeton, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers